WEST PHARMACEUTICAL Aktie

>WEST PHARMA Aktienkurs

219.5 EUR +0.6% (TradegateBSX)

Ask: 221.6 EUR / 15 Stück

Bid: 220.3 EUR / 15 Stück

Tagesumsatz: 50 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

WEST PHARMA Aktie über LYNX handeln

Intraday

1 Jahr

>WEST PHARMA Performance

1 Woche: +2,1%

1 Monat: +2,7%

3 Monate: -5,7%

6 Monate: -5,1%

1 Jahr: +10,9%

laufendes Jahr: -6,3%

>WEST PHARMACEUTICAL Aktie

Name:

WEST PHARMACEUTICAL SERVICES

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US9553061055 / 864330

Symbol/ Ticker:

WPS (Frankfurt) / WST (NYSE)

Kürzel:

FRA:WPS, ETR:WPS, WPS:GR, NYSE:WST

Index:

S&P500

Webseite:

https://www.westpharma.co..

Profil:

West Pharmaceutical Services, Inc. is a global leader in designing and manufacturing drug packaging and delivery solutions for pharmaceutical, biotechnology, and medical device industries. The company specializes in elastomeric and polymer components..
>Volltext..

Marktkapitalisierung:

15769.28 Mio. EUR

Unternehmenswert:

15373.46 Mio. EUR

Umsatz:

2663.66 Mio. EUR

EBITDA:

699.98 Mio. EUR

Nettogewinn:

427.7 Mio. EUR

Gewinn je Aktie:

5.92 EUR

Schulden:

282.59 Mio. EUR

Liquide Mittel:

685.51 Mio. EUR

Operativer Cashflow:

653.89 Mio. EUR

Bargeldquote:

1.21

Umsatzwachstum:

-6.31%

Gewinnwachstum:

-11.68%

Dividende je Aktie:

0.73 EUR

Dividendenrendite:

0.35%

Dividendenschätzung:

0.36%

Div. Historie:

28.01.26 - 0.184118€
12.11.25 - 0.18900199€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

WEST PHARMACEUTICAL, WEST PHARMA, WEST PHARMACEUTICALS

Letzte Datenerhebung:

06.04.26

>WEST PHARMA Kennzahlen

Aktien/ Unternehmen:

Aktien: 72.02 Mio. St.

Frei handelbar: 99.37%

Leerverk. Aktien: 3.56%

Rückkaufquote: 0.64%

Mitarbeiter: 10800

Umsatz/Mitarb.: 0.25 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 26.77%

Bewertung:

KGV: 37.72

KGV lG: 31.37

KUV: 5.88

KBV: 5.81

PEG-Ratio: 23.62

EV/EBITDA: 21.96

Rentabilität:

Bruttomarge: 35.92%

Gewinnmarge: 16.06%

Operative Marge: 20.7%

Managementeffizenz:

Gesamtkaprendite: 12.48%

Eigenkaprendite: 16.85%

>WEST PHARMA Peer Group

Gesundheit, Impfstoffentwicklung/ Impfstoffhersteller, Medizinprodukte & -technik/ Implantate/ Wundpflege

>WEST PHARMA Chart & Kurs - NYSE

>WEST PHARMA News

01.04.26 - 19:45	WST Expands Dublin Facility to Boost Injectable Therapy Capacity (Zacks)
	West Pharmaceutical expands Dublin facility to boost injectable therapy capacity and strengthen its end-to-end manufacturing platform....

31.03.26 - 17:48	West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity (PR Newswire)
	EXTON, Pa., March 31, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the opening of its new building at its current site in Damastown, Dublin. The 165,000 square foot......

18.03.26 - 20:12	West Pharmaceutical Services skizziert Wachstumsstrategie auf KeyBanc Forum (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

16.03.26 - 16:30	The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services (Zacks)
	Dividend Aristocrats like Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services offer steady income as geopolitical tensions and oil price spikes rattle markets....

13.03.26 - 21:45	3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis (Zacks)
	Middle East tensions rattle markets as oil tops $100. Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services stand out as dividend aristocrats for stability....

11.03.26 - 19:30	Reasons to Add West Pharmaceutical Stock to Your Portfolio Right Now (Zacks)
	WST eyes growth from high-value components, GLP-1 drug demand and Annex 1 conversions, but generics destocking and European capacity constraints pose risks....

10.03.26 - 16:06	West Pharmaceutical auf Barclays-Konferenz: Strategische Neuausrichtung und Wachstumsprognosen (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

10.03.26 - 02:48	West Pharmaceutical Services President And CEO Eric Green To Retire (AFX)
	WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST) announced that Eric Green plans to retire from his positions as President, Chief Executive Officer and Chair of the Board of the Com......

09.03.26 - 21:46	West Pharmaceutical Services CEO Eric Green plans to retire after successor is named (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.03.26 - 21:33	Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc. (PR Newswire)
	EXTON, Pa., March 9, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that Eric M. Green has informed the Board of Directors that he plans to retire from his positions as President, Chief Executive Officer and Chair of the Board of the Company once his......

27.02.26 - 12:03	West to Participate in Upcoming Investor Conferences (PR Newswire)
	EXTON, Pa., Feb. 27, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Barclays Global Healthcare Conference:......

25.02.26 - 17:30	Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term (Zacks)
	Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

23.02.26 - 17:31	Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 32.33%: Read This Before Placing a Bet (Zacks)
	The mean of analysts' price targets for West Pharmaceutical (WST) points to a 32.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock....

20.02.26 - 15:12	Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

17.02.26 - 23:24	West Pharmaceutical announces up to $1B share repurchase program (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

17.02.26 - 22:03	West Announces Quarterly Dividend and Share Repurchase Program (PR Newswire)
	EXTON, Pa., Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's......

15.02.26 - 18:13

West Pharmaceutical’s Under-the-Radar Dividend Worth Watching (24/7 Wall St.)

West Pharmaceutical Services just sent investors $0.22 per share on February 4, 2026, marking the company's latest quarterly dividend payment. For a business that's quietly grown its payout for over a decade, the real question isn't whether WST pays dividends – it's whether this 0.34% yield deserves a place in income-focused portfolios. The Dividend Profile: ... West Pharmaceutical's Under-the-Radar Dividend Worth Watching The post West Pharmaceutical's Under-the-Radar Dividend Worth Watching appeared first on 24/7 Wall St.....

12.02.26 - 20:30	WST′s Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up (Zacks)
	West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook....

12.02.26 - 20:21	West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 16:45	West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
	Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram